Ginkgo Bioworks Holdings
Biotechnology
Healthcare
DNA
54.86 M shares
NYSE US
traded
23 Sep 2025
listed
no
open
12.24
52 week high
16.36
high
12.85
52 week low
0.00
low
12.01
growth
54.18 %
previous Close
12.03
P/E ratio
-11
market cap
618 M
div yield
0
usd
Jun 2025
qoq
revenue
49.60 M
2.66 %
net incoming
-60.30 M
33.70 %
eps
-1.10 %
34.52 %
eps surprise
-1000.00 %
net profit margin
-121.56 %
66.00 %
operating incoming
-65.54 M
26.33 %
net change in cash
-105.85 M
57.72 %
cash on hand
204 M
-34.84 %
cost of revenue
9.44 M
-21.62 %
top top